Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics

참고문헌 (205)

1. Kinlay, S., "Role of endothelial dysfunction in coronary artery disease and implications for therapy", Am. J. Cardiol, 80, pp.11I~16I (1997)
2. Panza, J. A., "Abnormal endotheliumdependent vascular relaxation in patients with essential hypertension", N. Engl. J. Med, 323, pp.22~27 (1990)
3. Donato, A. J., "Mechanisms of dysfunction in the aging vasculature and role in age-related disease", Circ. Res, 123, pp.825~848 (2018)
4. Cosentino, F., "Endothelial dysfunction and stroke", J. Cardiovasc. Pharmacol, 38, pp.S75~S78 (2001)
5. Finger, C. E., "Age-related immune alterations and cerebrovascular inflammation", Mol. Psychiatry, 27, pp.803~818 (2022)
6. Shang, X., "Associations of ophthalmic and systemic conditions with incident dementia in the UK Biobank", Br. J. Ophthalmol (2021)[DOI]
7. Javaheri, S., "Sleep apnea : types, mechanisms, and clinical cardiovascular consequences", J. Am. Coll. Cardiol, 69, pp.841~858 (2017)
8. Wu, C. -M., "The emerging role of cell senescence in atherosclerosis", Clin. Chem. Lab. Med, 59, pp.27~38 (2020)
9. Minamino, T., "Endothelial cell senescence in human atherosclerosis : role of telomere in endothelial dysfunction", Circulation, 105, pp.1541~1544 (2002)
10. Jia, L., "Haplodeficiency of ataxia telangiectasia mutated accelerates heart failure after myocardial infarction", J. Am. Heart Assoc, 6, pp.e006349~ (2017)
11. van der Feen, D. E., "Converging paths of pulmonary arterial hypertension and cellular senescence", Am. J. Respir. Cell Mol. Biol, 61, pp.11~20 (2019)
12. van der Feen, D. E., "Cellular senescence impairs the reversibility of pulmonary arterial hypertension", Sci. Transl. Med, 12, pp.eaaw4974~ (2020)
13. Sugimoto, K., "Senescence marker protein 30 deficiency exacerbates pulmonary hypertension in hypoxia-exposed mice", Int. Heart J, 60, pp.1430~1434 (2019)
14. Jia, G., "Vascular stiffness in insulin resistance and obesity", Front. Physiol, 6, pp.231~ (2015)
15. Palmer, A. K., "Cellular senescence in type 2 diabetes : a therapeutic opportunity", Diabetes, 64, pp.2289~2298 (2015)
16. Shakeri, H., "Cellular senescence links aging and diabetes in cardiovascular disease", Am. J. Physiol. Heart Circ. Physiol, 315, pp.H448~H462 (2018)
17. Mitchell, G. F., "Arterial stiffness and cardiovascular events : the Framingham Heart Study", Circulation, 121, pp.505~511 (2010)
18. Wang, M., "Editorial : arterial aging and ageassociated arterial diseases", Front. Genet, 9, pp.444~ (2018)
19. Ferrini, M. G., "Aging related erectile dysfunction-potential mechanism to halt or delay its onset", Transl. Androl. Urol, 6, pp.20~27 (2017)
20. Tuttolomondo, A., "Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome", Cardiovasc. Diabetol, 16, pp.2~ (2017)
21. Sierra, F., "Geroscience and the trans-NIH Geroscience Interest Group, GSIG", Geroscience, 39, pp.1~5 (2017)
22. Spyridopoulos, I., "Oncogenic ras induces premature senescence in endothelial cells : role of p21(Cip1", Waf1), 2002, pp.97, 117~124
23. Chang, E., "Telomere length and replicative aging in human vascular tissues", Proc. Natl Acad. Sci. USA, 92, pp.11190~11194 (1995)
24. Zhan, H., "Ataxia telangiectasia mutated(ATM)-mediated DNA damage response in oxidative stress-induced vascular endothelial cell senescence", J. Biol. Chem, 285, pp.29662~29670 (2010)
25. Dai, D. -F., "Mitochondria and cardiovascular aging", Circ. Res, 110, pp.1109~1124 (2012)
26. Ungvari, Z., "Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats", Am. J. Physiol. Heart Circ. Physiol, 294, pp.H2121~H2128 (2008)
27. Kurz, D. J., "Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells", J. Cell Sci, 117, pp.2417~2426 (2004)
28. Donato, A. J., "Cellular and molecular biology of aging endothelial cells", J. Mol. Cell. Cardiol, 89, pp.122~135 (2015)
29. Faget, D. V., "Unmasking senescence: context-dependent effects of SASP in cancer", Nat. Rev. Cancer, 19, pp.439~453 (2019)
30. Ungvari, Z., "Endothelial dysfunction and angiogenesis impairment in the ageing vasculature", Nat. Rev. Cardiol, 15, pp.555~565 (2018)
31. Du, X. L., "Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site", J. Clin. Invest, 108, pp.1341~1348 (2001)
32. Jia, G., "Endothelial cell senescence in agingrelated vascular dysfunction", Biochim. Biophys. Acta Mol. Basis Dis, 1865, pp.1802~1809 (2019)
33. Tian, F., "κ-opioid receptor stimulation improves endothelial function via Akt-stimulated NO production in hyperlipidemic rats", Sci. Rep, 6, pp.26807~ (2016)
34. Ying, L., "Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2", AMPKα signaling pathway, 2019, pp.10, 665~
35. Yan, J., "Fibroblast growth factor 21 delayed endothelial replicative senescence and protected cells from H2O2-induced premature senescence through SIRT1", Am. J. Transl. Res, 9, pp.4492~4501 (2017)
36. Miyauchi, H., "Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53", p21-dependent pathway, 2004, pp.23, 212~220
37. Astle, M. V., "AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage : implications for targeting mTOR during malignancy", Oncogene, 31, pp.1949~1962 (2012)
38. Khor, E. -S., "The roles of MTOR and miRNAs in endothelial cell senescence", Biogerontology, 21, pp.517~530 (2020)
39. Mattagajasingh, I., "SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase", Proc. Natl Acad. Sci. USA, 104, pp.14855~14860 (2007)
40. Donato, A. J., "SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans", J. Physiol, 589, pp.4545~4554 (2011)
41. Ota, H., "Sirt1 modulates premature senescence-like phenotype in human endothelial cells", J. Mol. Cell. Cardiol, 43, pp.571~579 (2007)
42. Yoon, H. E., "Age-associated changes in the vascular renin-angiotensin system in mice", Oxid. Med. Cell. Longev, 2016, pp.6731093~ (2016)
43. Uryga, A. K., "Ageing induced vascular smooth muscle cell senescence in atherosclerosis", J. Physiol, 594, pp.2115~2124 (2016)
44. Freeman, B. D., "Endothelin-1and its role in the pathogenesis of infectious diseases", Life Sci, 118, pp.110~119 (2014)
45. Zeiher, A. M., "Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes", Lancet, 344, pp.1405~1406 (1994)
46. Đambić, V, "Selected Chapters from the Renin-Angiotensin System" (2020), IntechOpen
47. Beckman, J. S., "Nitric oxide, superoxide, and peroxynitrite : the good, the bad, and ugly", Am. J. Physiol, 271, pp.C1424~C1437 (1996)
48. Förstermann, U., "Endothelial nitric oxide synthase in vascular disease : from marvel to menace", Circulation, 113, pp.1708~1714 (2006)
49. Kietadisorn, R., "Tackling endothelial dysfunction by modulating NOS uncoupling : new insights into its pathogenesis and therapeutic possibilities", Am. J. Physiol. Endocrinol. Metab, 302, pp.E481~E495 (2012)
50. Lemarié, C. A., "Mthfr deficiency induces endothelial progenitor cell senescence via uncoupling of eNOS and downregulation of SIRT1", Am. J. Physiol. Heart Circ. Physiol, 300, pp.H745~H753 (2011)
51. You, Y., "Inhibition of S-adenosylhomocysteine hydrolase induces endothelial senescence via hTERT downregulation", Atherosclerosis, 353, pp.1~10 (2022)
52. Campisi, J., "Cellular senescence : when bad things happen to good cells", Nat. Rev. Mol. Cell Biol, 8, pp.729~740 (2007)
53. Collado, M., "Senescence in tumours : evidence from mice and humans", Nat. Rev. Cancer, 10, pp.51~57 (2010)
54. Kuosmanen, S. M., "MicroRNAs mediate the senescence-associated decline of NRF2 in endothelial cells", Redox Biol, 18, pp.77~83 (2018)
55. Kuosmanen, S. M., "NRF2 regulates endothelial glycolysis and proliferation with miR-93 and mediates the effects of oxidized phospholipids on endothelial activation", Nucleic Acids Res, 46, pp.1124~1138 (2018)
56. Unterluggauer, H., "Premature senescence of human endothelial cells induced by inhibition of glutaminase", Biogerontology, 9, pp.247~259 (2008)
57. Stabenow, L. K., "Oxidative glucose metabolism promotes senescence in vascular endothelial cells", Cells, 11, pp.2213~ (2022)
58. Peyton, K. J., "Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells", Biochem. Pharmacol, 156, pp.204~214 (2018)
59. Leopold, J. A., "Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide", Arterioscler. Thromb. Vasc. Biol, 23, pp.411~417 (2003)
60. Park, H. S., "Endothelial cell senescence : a machine learning-based meta-analysis of transcriptomic studies", Ageing Res. Rev, 65, pp.101213~ (2021)
61. Parsanathan, R., "Glucose-6-phosphate dehydrogenase deficiency increases cell adhesion molecules and activates human monocyte-endothelial cell adhesion : protective role of l-cysteine", Arch. Biochem. Biophys, 663, pp.11~21 (2019)
62. Vandekeere, S., "Serine synthesis via PHGDH is essential for heme production in endothelial cells", Cell Metab, 28, pp.573~587 (2018)
63. Bloom, S. I., "Mechanisms and consequences of endothelial cell senescence", Nat. Rev. Cardiol (2022)[DOI]
64. Kotla, S., "Endothelial senescence is induced by phosphorylation and nuclear export of telomeric repeat binding factor 2-interacting protein", JCI Insight, 4, pp.e124867~ (2019)
65. Warboys, C. M., "Disturbed flow promotes endothelial senescence via a p53-dependent pathway", Arterioscler. Thromb. Vasc. Biol, 34, pp.985~995 (2014)
66. Parrinello, S., "Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts", Nat. Cell Biol, 5, pp.741~747 (2003)
67. Chen, Q., "Oxidative DNA damage and senescence of human diploid fibroblast cells", Proc. Natl Acad. Sci. USA, 92, pp.4337~4341 (1995)
68. von Zglinicki, T., "Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?", Exp. Cell Res, 220, pp.186~193 (1995)
69. Rogers, S. C., "Exposure to high or low glucose levels accelerates the appearance of markers of endothelial cell senescence and induces dysregulation of nitric oxide synthase", J. Gerontol. A Biol. Sci. Med. Sci, 68, pp.1469~1481 (2013)
70. Maeda, M., "Intermittent high glucose implements stress-induced senescence in human vascular endothelial cells : role of superoxide production by NADPH oxidase", PLoS ONE, 10, pp.e0123169~ (2015)
71. Yu, M. -A., "Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction", J. Hypertens, 28, pp.1234~1242 (2010)
72. Vlassara, H., "Advanced glycation end products(AGE)and diabetes : cause, effect, or both? Curr", Diab. Rep, 14, pp.453~ (2014)
73. Senatus, L. M., "The AGE-RAGE axis : implications for ageassociated arterial diseases", Front. Genet, 8, pp.187~ (2017)
74. Chen, Y., "p53 SUMOylation mediates AOPP-induced endothelial senescence and apoptosis evasion", Front. Cardiovasc. Med, 8, pp.795747~ (2021)
75. Morel, O., "Cellular mechanisms underlying the formation of circulating microparticles", Arterioscler. Thromb. Vasc. Biol, 31, pp.15~26 (2011)
76. Brodsky, S. V., "Endothelium-derived microparticles impair endothelial function in vitro", Am. J. Physiol. Heart Circ. Physiol, 286, pp.H1910~H1915 (2004)
77. Mostefai, H. A., "Phosphatidylinositol 3-kinase and xanthine oxidase regulate nitric oxide and reactive oxygen species productions by apoptotic lymphocyte microparticles in endothelial cells", J. Immunol, 180, pp.5028~5035 (2008)
78. Abbas, M., "Endothelial microparticles from acute coronary syndrome patients induce premature coronary artery endothelial cell aging and thrombogenicity : role of the Ang II", AT1 receptor, Circulation, pp.2017, 135[DOI]
79. Graves, S. I, "Implicating endothelial cell senescence to dysfunction in the ageing and diseased brain", Basic Clin. Pharmacol. Toxicol, 127, pp.102~110 (2020)
80. Wang, W. -J., "Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease", Oncotarget, 5, pp.64520~64533 (2017)
81. Cohen, C., "Glomerular endothelial cell senescence drives age-related kidney disease through PAI-1", EMBO Mol. Med, 13, pp.e14146~ (2021)
82. Erusalimsky, J. D, "Vascular endothelial senescence : from mechanisms to pathophysiology", J. Appl. Physiol, 106, pp.326~332 (2009)
83. Yang, J., "Human endothelial cell life extension by telomerase expression", J. Biol. Chem, 274, pp.26141~26148 (1999)
84. Franco, S., "Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres", Cancer Res, 62, pp.552~559 (2002)
85. Potente, M., "SIRT1 controls endothelial angiogenic functions during vascular growth", Genes Dev, 21, pp.2644~2658 (2007)
86. Lähteenvuo, J., "Effects of aging on angiogenesis", Circ. Res, 110, pp.1252~1264 (2012)
87. Zieman, S. J., "Mechanisms, pathophysiology, and therapy of arterial stiffness", Arterioscler. Thromb. Vasc. Biol, 25, pp.932~943 (2005)
88. Kaess, B. M., "Aortic stiffness, blood pressure progression, and incident hypertension", JAMA, 308, pp.875~881 (2012)
89. Hoffmann, J., "Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli : important role of nitric oxide", Circ. Res, 89, pp.709~715 (2001)
90. Nakajima, M., "Aging decreases the production of PGI2 in rat aortic endothelial cells", Exp. Gerontol, 32, pp.685~693 (1997)
91. Matsushita, H., "eNOS activity is reduced in senescent human endothelial cells : Preservation by hTERT immortalization", Circ. Res, 89, pp.793~798 (2001)
92. Taddei, S., "Endothelium, aging, and hypertension", Curr. Hypertens. Rep, 8, pp.84~89 (2006)
93. Eriksson, M., "Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome", Nature, 423, pp.293~298 (2003)
94. Goldman, R. D., "Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome", Proc. Natl Acad. Sci. USA, 101, pp.8963~8968 (2004)
95. McClintock, D., "Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody", Proc. Natl Acad. Sci. USA, 103, pp.2154~2159 (2006)
96. Olive, M., "Cardiovascular pathology in Hutchinson-Gilford progeria : correlation with the vascular pathology of aging", Arterioscler. Thromb. Vasc. Biol, 30, pp.2301~2309 (2010)
97. Laarmann, K., "Werner syndrome(WRN)DNA helicase and base excision repair(BER)factors maintain endothelial homeostasis", DNA Repair, 73, pp.17~27 (2019)
98. Prakash, A., "Cardiac abnormalities in patients with Hutchinson-Gilford progeria syndrome", JAMA Cardiol, 3, pp.326~334 (2018)
99. Xu, S., "Hutchinson-Gilford progeria syndrome: cardiovascular pathologies and potential therapies", Trends Biochem. Sci, 44, pp.561~564 (2019)
100. Kato, H., "Atherosclerosis and cardiovascular diseases in progeroid syndromes", J. Atheroscler. Thromb, 29, pp.439~447 (2022)
101. "Unable to find information for 9014341", ~
102. Mojiri, A., "Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice", Eur. Heart J, 42, pp.4352~4369 (2021)
103. Bidault, G., "Progerin expression induces inflammation, oxidative stress and senescence in human coronary endothelial cells", Cells, 9, pp.1201~ (2020)
104. Rouhi, L., "Deletion of the Lmna gene in fibroblasts causes senescenceassociated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype", J. Cardiovasc. Aging, 2, pp.30~ (2022)
105. Dore, M. P., "The elderly with glucose-6-phosphate dehydrogenase deficiency are more susceptible to cardiovascular disease", J. Atheroscler. Thromb, 28, pp.604~610 (2021)
106. Thomas, J. E., "Glucose-6-phosphate dehydrogenase deficiency is associated with cardiovascular disease in U.S. military centers", Tex. Heart Inst. J, 45, pp.144~150 (2018)
107. Lee, B. Y., "Senescence-associated beta-galactosidase is lysosomal betagalactosidase", Aging Cell, 5, pp.187~195 (2006)
108. López-Luppo, M., "Cellular senescence is associated with human retinal microaneurysm formation during aging", Invest. Ophthalmol. Vis. Sci, 58, pp.2832~2842 (2017)
109. Vasile, E., "Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF", VEGF : evidence for senescent endothelial cells in vivo at sites of atherosclerosis, 2001, pp.15, 458~466
110. Villaret, A., "Adipose tissue endothelial cells from obese human subjects : differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence", Diabetes, 59, pp.2755~2763 (2010)
111. Ogami, M., "Telomere shortening in human coronary artery diseases", Arterioscler. Thromb. Vasc. Biol, 24, pp.546~550 (2004)
112. Okuda, K., "Telomere attrition of the human abdominal aorta : relationships with age and atherosclerosis", Atherosclerosis, 152, pp.391~398 (2000)
113. Krishnamurthy, J., "p16INK4a induces an age-dependent decline in islet regenerative potential", Nature, 443, pp.453~457 (2006)
114. Song, H., "Increased p53protein expression in human failing myocardium", J. Heart Lung Transplant, 18, pp.744~749 (1999)
115. Predmore, J. M., "Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies", Circulation, 121, pp.997~1004 (2010)
116. Yang, N. -C., "The limitations and validities of senescence associatedbeta-galactosidase activity as an aging marker for human foreskin fibroblast Hs68 cells", Exp. Gerontol, 40, pp.813~819 (2005)
117. Tuttle, C. S. L., "Senescence in tissue samples of humans with age-related diseases : a systematic review", Ageing Res. Rev, 68, pp.101334~ (2021)
118. Shapiro, G. I., "Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines", Cancer Res, 55, pp.505~509 (1995)
119. Yamakoshi, K., "Real-time in vivo imaging of p16Ink4a reveals cross talk with p53", J. Cell Biol, 186, pp.393~407 (2009)
120. Herbig, U., "Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a)", Mol. Cell, 4, pp.501~513 (2004)
121. Biran, A., "Quantitative identification of senescent cells in aging and disease", Aging Cell, 16, pp.661~671 (2017)
122. Kustanovich, A., "Life and death of circulating cell-free DNA", Cancer Biol. Ther, 20, pp.1057~1067 (2019)
123. Pompilio, G., "Endothelial progenitor cells and cardiovascular homeostasis : clinical implications", Int. J. Cardiol, 131, pp.156~167 (2009)
124. Medina, R. J., "Endothelial progenitors as tools to study vascular disease", Stem Cells Int, 2, pp.346735~ (2012)
125. Zhu, J., "Safety and efficacy of autologous thymosin β4 pre-treated endothelial progenitor cell transplantation in patients with acute ST segment elevation myocardial infarction : a pilot study", Cytotherapy, 18, pp.1037~1042 (2016)
126. D’Avola, D., "Phase 1-2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow-derived endothelial progenitor cells", Transl. Res, 188, pp.80~91 (2017)
127. Jie, K. E., "Circulating endothelial progenitor cell levels are higher during childhood than in adult life", Atherosclerosis, 202, pp.345~347 (2009)
128. Tepper, O. M., "Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures", Circulation, 106, pp.2781~2786 (2002)
129. Umemura, T., "Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells", Am. J. Hypertens, 21, pp.1203~1209 (2008)
130. Vasa, M., "Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease", Circ. Res, 89, pp.E1~E7 (2001)
131. Wang, Y., "Elevated circulating HtrA4 in preeclampsia may alter endothelial expression of senescence genes", Placenta, 90, pp.71~81 (2020)
132. Paschalaki, K. E., "Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence", Stem Cells, 31, pp.2813~2826 (2013)
133. Burger, D., "Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells : implications in vascular senescence", J. Am. Heart Assoc, 1, pp.e001842~ (2012)
134. Mause, S. F., "Microparticles : protagonists of a novel communication network for intercellular information exchange", Circ. Res, 107, pp.1047~1057 (2010)
135. VanWijk, M. J., "Microparticles in cardiovascular diseases", Cardiovasc. Res, 59, pp.277~287 (2003)
136. Simoncini, S., "Biogenesis of pro-senescent microparticles by endothelial colony forming cells from premature neonates is driven by SIRT1-dependent epigenetic regulation of MKK6", Sci. Rep, 7, pp.8277~ (2017)
137. Simak, J., "Circulating endothelial microparticles in acute ischemic stroke : a link to severity, lesion volume and outcome", J. Thromb. Haemost, 4, pp.1296~1302 (2006)
138. Wang, J. M., "Elevated circulating endothelial microparticles and brachialankle pulse wave velocity in well-controlled hypertensive patients", J. Hum. Hypertens, 23, pp.307~315 (2009)
139. Preston, R. A., "Effects of severe hypertension on endothelial and platelet microparticles", Hypertension, 41, pp.211~217 (2003)
140. Montoro-García, S., "Small-size microparticles as indicators of acute decompensated state in ischemic heart failure", Rev. Esp. Cardiol, 68, pp.951~958 (2015)
141. Palmirotta, R., "Liquid biopsy of cancer : a multimodal diagnostic tool in clinical oncology", Ther. Adv. Med. Oncol, 10, pp.1758835918794630~ (2018)
142. Lone, S. N., "Liquid biopsy : a step closer to transform diagnosis, prognosis and future of cancer treatments", Mol. Cancer, 21, pp.79~ (2022)
143. Cai, Y., "Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice", Cell Res, 30, pp.574~589 (2020)
144. Quintas-Cardama, A., "Dasatinib(BMS-354825)is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib(AMN107)therapy failure", Blood, 109, pp.497~499 (2007)
145. Talpaz, M., "Dasatinib in imatinib-resistant Philadelphia chromosomepositive leukemias", N. Engl. J. Med, 354, pp.2531~2541 (2006)
146. Zhu, Y., "The Achilles’ heel of senescent cells : from transcriptome to senolytic drugs", Aging Cell, 14, pp.644~658 (2015)
147. Fan, T., "Senolytics cocktail dasatinib and quercetin alleviate human umbilical vein endothelial cell senescence via the TRAF6-MAPK-NF-κB Axis in a YTHDF2-dependent manner", Gerontology, 68, pp.920~934 (2022)
148. Ogrodnik, M., "Cellular senescence drives age-dependent hepatic steatosis", Nat. Commun, 8, pp.15691~ (2017)
149. Hohmann, M. S., "Quercetin enhances ligand-induced apoptosis in senescent idiopathic pulmonary fibrosis fibroblasts and reduces lung fibrosis in vivo", Am. J. Respir. Cell Mol. Biol, 60, pp.28~40 (2019)
150. Verma, R., "Evaluating the ameliorative potential of quercetin against the bleomycin-induced pulmonary fibrosis in wistar rats", Pulm. Med, 2013, pp.921724~ (2013)
151. Salaami, O., "Antidiabetic effects of the senolytic agent dasatinib", Mayo Clin. Proc, 96, pp.3021~3029 (2021)
152. Justice, J. N., "Senolytics in idiopathic pulmonary fibrosis : Results from a firstin-human, open-label, pilot study", EBioMedicine, 40, pp.554~563 (2019)
153. Zhu, Y., "New agents that target senescent cells : the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463", Aging(Albany NY), 9, pp.955~963 (2017)
154. Zhu, Y., "Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors", Aging Cell, 15, pp.428~435 (2016)
155. Yousefzadeh, M. J., "Fisetin is a senotherapeutic that extends health and lifespan", EBioMedicine, 36, pp.18~28 (2018)
156. Moncsek, A., "Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout(Mdr2-", -)mice, 2018, pp.67, 247~259
157. Chang, J., "Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice", Nat. Med, 22, pp.78~83 (2016)
158. Childs, B. G., "Senescent intimal foam cells are deleterious at all stages of atherosclerosis", Science, 354, pp.472~477 (2016)
159. Johmura, Y., "Senolysis by glutaminolysis inhibition ameliorates various ageassociated disorders", Science, 371, pp.265~270 (2021)
160. Shosha, E., "Mechanisms of diabetes-induced endothelial cell senescence : role of arginase 1", Int. J. Mol. Sci, 19, pp.1215~ (2018)
161. Caland, L., "Knockdown of angiopoietin-like 2 induces clearance of vascular endothelial senescent cells by apoptosis, promotes endothelial repair and slows atherogenesis in mice", Aging, 11, pp.3832~3850 (2019)
162. Miller, R. A., "An Aging Interventions Testing Program : study design and interim report", Aging Cell, 6, pp.565~575 (2007)
163. "Supported Interventions | National Institute on Aging"[URL]
164. Hwang, H. V., "Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells", PLoS One, 13, pp.e0190374~ (2018)
165. Rosenzweig, S. A., "Acquired resistance to drugs targeting tyrosine kinases", Adv. Cancer Res, 138, pp.71~98 (2018)
166. Song, S., "Targeting senescent cells for a healthier aging : challenges and opportunities", Adv. Sci, 7, pp.2002611~ (2020)
167. Harrison, C. N., "Ruxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence", Leuk. Lymphoma, 57, pp.2259~2267 (2016)
168. Moiseeva, O., "Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK", NF-κB activation, 2013, pp.12, 489~498
169. Csiszar, A., "Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells : role of NF-kappaB inhibition", Am. J. Physiol. Heart Circ. Physiol, 291, pp.H1694~H1699 (2006)
170. Xia, L., "Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms", Br. J. Pharmacol, 155, pp.387~394 (2008)
171. Shen, X., "Resveratrol prevents endothelial progenitor cells from senescence and reduces the oxidative reaction via PPAR‑γ", HO‑1 pathways, 2016, pp.14, 5528~5534
172. Arunachalam, G., "Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1", Br. J. Pharmacol, 171, pp.523~535 (2014)
173. Xu, M., "JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age", Proc. Natl Acad. Sci. USA, 112, pp.E6301~E6310 (2015)
174. Sin, T. K., "Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis", J. Physiol, 593, pp.1887~1899 (2015)
175. Kim, E. N., "The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system", Atherosclerosis, 270, pp.123~131 (2018)
176. Sena, C. M., "Metformin restores endothelial function in aorta of diabetic rats", Br. J. Pharmacol, 163, pp.424~437 (2011)
177. Houssaini, A., "mTOR pathway activation drives lung cell senescence and emphysema", JCI Insight, 3, pp.e93203~ (2018)
178. Flynn, J. M., "Late-life rapamycin treatment reverses age-related heart dysfunction", Aging Cell, 12, pp.851~862 (2013)
179. Lesniewski, L. A., "Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways", Aging Cell, 16, pp.17~26 (2017)
180. Youm, Y. -H., "Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution", Proc. Natl Acad. Sci. USA, 113, pp.1026~1031 (2016)
181. Zhang, Y., "The starvation hormone, fibroblast growth factor-21, extends lifespan in mice", eLife, 1, pp.e00065~ (2012)
182. Hoare, M., "NOTCH1 mediates a switch between two distinct secretomes during senescence", Nat. Cell Biol, 18, pp.979~992 (2016)
183. Yin, K., "Senescence-induced endothelial phenotypes underpin immunemediated senescence surveillance", Genes Dev, 36, pp.533~549 (2022)
184. Cho, J. H., "CD9 induces cellular senescence and aggravates atherosclerotic plaque formation", Cell Death Differ, 27, pp.2681~2696 (2020)
185. Pham, L. M., "Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis", Biomaterials, 269, pp.120677~ (2021)
186. Amor, C., "Senolytic CAR T cells reverse senescence-associated pathologies", Nature, 583, pp.127~132 (2020)
187. Ruscetti, M., "Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer", Cell, 181, pp.424~441 (2020)
188. Rigato, I., "Bilirubin and the risk of common nonhepatic diseases", Trends Mol. Med, 11, pp.277~283 (2005)
189. Marconi, V. C., "Bilirubin is inversely associated with cardiovascular disease among HIV-positive and HIV-negative individuals in VACS(Veterans Aging Cohort Study)", J. Am. Heart Assoc, 7, pp.e007792~ (2018)
190. Boland, B. S., "Association of serum bilirubin with aging and mortality", J. Clin. Exp. Hepatol, 4, pp.1~7 (2014)
191. Vítek, L., "Bilirubin chemistry and metabolism; harmful and protective aspects", Curr. Pharm. Des, 15, pp.2869~2883 (2009)
192. Nitti, M., "Heme oxygenase dependent bilirubin generation in vascular cells : a role in preventing endothelial dysfunction in local tissue microenvironment?", Front. Physiol, 11, pp.23~ (2020)
193. 김성영, "Biliverdin reductase A in the prevention of cellular senescence against oxidative stress", Experimental and Molecular Medicine, 43(1), pp.15~23 (2011), 생화학분자생물학회
194. Savas, J. N., "Extremely long-lived nuclear pore proteins in the rat brain", Science, 335, pp.942~ (2012)
195. Ori, A., "Integrated transcriptome and proteome analyses reveal organspecific proteome deterioration in old rats", Cell Syst, 1, pp.224~237 (2015)
196. Kim, S. Y., "Senescence-related functional nuclear barrier by downregulation of nucleo-cytoplasmic trafficking gene expression", Biochem. Biophys. Res. Commun, 391, pp.28~32 (2010)
197. 김성영, "Global transcriptional downregulation of TREX and nuclear trafficking machinery as pan-senescence phenomena: evidence from human cells and tissues", Experimental and Molecular Medicine, 52, pp.1~9 (2020), 생화학분자생물학회[DOI]
198. Huang, Y., "Biliverdin reductase A protects lens epithelial cells against oxidative damage and cellular senescence in age-related cataract", Oxid. Med. Cell. Longev, 2022, pp.5628946~ (2022)
199. Park Ji-Hwan, "Disruption of nucleocytoplasmic trafficking as a cellular senescence driver", Experimental and Molecular Medicine, 53, pp.1~17 (2021), 생화학분자생물학회[DOI]
200. Grosse, L., "Defined p16 high senescent cell types are indispensable for mouse healthspan", Cell Metab, 32, pp.87~99 (2020)
201. Garrido, A. M., "Efficacy and limitations of senolysis in atherosclerosis", Cardiovasc. Res, 118, pp.1713~1727 (2022)
202. French, L. E., "Fas and Fas ligand in embryos and adult mice : ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover", J. Cell Biol, 133, pp.335~343 (1996)
203. Tan, P. H., "Phenotypic and functional differences between human saphenous vein(HSVEC)and umbilical vein(HUVEC)endothelial cells", Atherosclerosis, 173, pp.171~183 (2004)
204. Kile, B. T., "The role of apoptosis in megakaryocytes and platelets", Br. J. Haematol, 165, pp.217~226 (2014)
205. Muñoz-Espín, D., "A versatile drug delivery system targeting senescent cells", EMBO Mol. Med, 10, pp.e9355~ (2018)

관련 논문AI추천